Ovid Therapeutics Inc (OVID) insider trading
Every open-market stock purchase and sale by Ovid Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $116K over the last 12 months (1 buy).
- Insiders sold $29.3K over the last 12 months (2 sales).
- Last insider buy: Jeremy M Levin (CEO), $66.3K, 10 months ago.
Last 12 months: insiders bought $116K (1 buy) and sold $29.3K (2 sales). Last close $2.60 on Jul 9, 2026.
Recent OVID insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 6, 2026 | Charles Ross Carter (CFO) | Bought (not open market) | — |
| Jun 15, 2026 | Anna Greka (Insider) | Bought (not open market) | — |
| Apr 7, 2026 | Kevin Joseph Fitzgerald (Insider) | Bought (not open market) | $45K |
| Apr 7, 2026 | Stelios Papadopoulos (Insider) | Bought (not open market) | $45K |
| Apr 7, 2026 | Bart Friedman (Insider) | Bought (not open market) | $22.5K |
| Mar 23, 2026 | Jeremy M Levin (Chair) | Bought (not open market) | — |
| Feb 26, 2026 | Jeremy M Levin (Insider) | Bought (not open market) | — |
| Feb 26, 2026 | Jeffrey A Rona (Insider) | Bought (not open market) | — |
| Feb 26, 2026 | Karen Bernstein (Insider) | Bought (not open market) | — |
| Feb 26, 2026 | Barbara Gayle Duncan (Insider) | Bought (not open market) | — |
| Feb 26, 2026 | Stelios Papadopoulos (Insider) | Bought (not open market) | — |
| Feb 26, 2026 | Jeffrey A Rona (Insider) | Bought (not open market) | — |
| Feb 26, 2026 | Bart Friedman (Insider) | Bought (not open market) | — |
| Feb 26, 2026 | Kevin Joseph Fitzgerald (Insider) | Bought (not open market) | — |
| Feb 26, 2026 | Margaret A. Alexander (CEO) | Bought (not open market) | — |
| Feb 23, 2026 | Margaret A. Alexander (CEO) | Sold | $16.9K |
| Feb 23, 2026 | Jeffrey A Rona (Insider) | Sold | $12.4K |
| Jan 4, 2026 | Margaret A. Alexander (CEO) | Bought (not open market) | — |
| Dec 15, 2025 | Jeremy M Levin (CEO) | Bought (not open market) | — |
| Dec 15, 2025 | Jeremy M Levin (CEO) | Bought (not open market) | — |
| Dec 11, 2025 | Jeremy M Levin (CEO) | Bought | $66.3K |
| Dec 11, 2025 | Jeremy M Levin (CEO) | Bought | $49.7K |
| Dec 11, 2025 | Jeremy M Levin (CEO) | Bought | — |
| Dec 8, 2025 | Takeda Pharmaceutical Co Ltd (10% owner) | Bought (not open market) | — |
| Dec 8, 2025 | Takeda Pharmaceutical Co Ltd (10% owner) | Bought (not open market) | — |
Who's trading OVID
- Charles Ross Carter, CFO: other filings, last Jul 6, 2026
- Anna Greka, Insider: other filings, last Jun 15, 2026
- Bart Friedman, Insider: other filings, last Apr 7, 2026
- Stelios Papadopoulos, Insider: other filings, last Apr 7, 2026
- Kevin Joseph Fitzgerald, Insider: other filings, last Apr 7, 2026
- Jeremy M Levin, CEO: bought $116K (3 buys), last Mar 23, 2026
- Margaret A. Alexander, COO: sold $16.9K (1 sale), last Feb 26, 2026
- Karen Bernstein, Insider: other filings, last Feb 26, 2026
- Barbara Gayle Duncan, Insider: other filings, last Feb 26, 2026
- Jeffrey A Rona, Insider: sold $12.4K (1 sale), last Feb 26, 2026
- Takeda Pharmaceutical Co Ltd, 10% owner: other filings, last Dec 8, 2025
Get free alerts when an insider at Ovid Therapeutics Inc files a new trade →